Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPLE PIE trial of esomeprazole for preeclampsia prevention
ACTRN12618000690257Phase 3Withdrawn
- Sponsor
- University of Melbourne
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Incidence of preeclampsia. Planned start Oct 2018; status: withdrawn.
02
Drugs
esomeprazole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ACTRN12618000690257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000690257.